相关实验视频

Updated: May 27, 2025

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

巴托内拉汉塞拉和阿斯伯吉勒斯黄菌在免疫受损患者的同时感染

Xu Mu¹, Shenghua Chen¹, Chunjing He¹

¹Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy Medical Sciences, Guangzhou 510080, People's Republic of China; Department of Burns and Wound Repair Surgery, Guangdong Provincial People's Hospital, Guangdong Academy Medical Sciences, Guangzhou 510080, People's Republic of China.

Diagnostic microbiology and infectious disease

|February 20, 2025

概括

患有COVID-19的免疫功能低下患者的非典型猫病 (CSD) 尽管接受了治疗,但仍出现了复发症状. 这凸显了在免疫抑制下管理CSD的挑战,以及对免疫评估的需要.

科学领域:

传染性疾病传染性疾病
免疫学免疫学免疫学

背景情况:

猫病 (CSD) 是由 Bartonella henselae 引起的.
免疫抑制疗法可能会使CSD管理复杂化.
同时感染,如COVID-19,可能会进一步影响疾病的发展.

研究的目的:

在免疫抑制治疗期间报告患有同时COVID-19感染的患者的非典型CSD病例.
突出在免疫抑制下病原体清除和症状复发方面的挑战.
强调需要在复杂病例中进行全面的免疫评估和精确诊断.

主要方法:

病例报告详细介绍了一名患有心血管疾病和结性脊柱炎的年轻女性患者在免疫抑制剂 (阿达利穆马布,巴里西提尼布) 的治疗方法.
通过宏基因组第二代测序证实了CSD的诊断.
药理和手术干预后临床结果的监测.

主要成果:

尽管在长期免疫受损状态下进行了药物和手术干预,但巴托内拉亨塞莱感染仍然存在.
由于病原体清除不完全,CSD症状的复发发生.
同时的COVID-19感染使治疗和康复过程复杂化.

结论:

免疫抑制,特别是在COVID-19等并发感染时,在完全清除Bartonella henselae方面带来了重大挑战.
重复出现的CSD症状强调了警免疫评估和准确诊断的重要性.
需要进一步的研究来了解免疫抑制,CSD和病毒感染之间的相互作用,以优化治疗策略.

关键词:

巴尔托内拉斯拉 (Bartonella henselae) 是一株植物.在 COVID-19 疫情中,猫病是猫病的一种疾病.免疫接种免疫接种感染感染感染下一代元基因组测序的测序.

更多相关视频

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions

Infection of Zebrafish Larvae with Aspergillus Spores for Analysis of Host-Pathogen Interactions

Published on: May 16, 2020

相关概念视频

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

Factors Affecting the Risk of Infection

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...